Declining trends in the incidence of Parkinson's disease: A cohort study in Germany

被引:0
|
作者
Fink, Anne [1 ]
Pavlou, Maria Angeliki S. [2 ]
Roomp, Kirsten [3 ,4 ]
Schneider, Jochen G. [2 ,3 ,4 ,5 ,6 ]
机构
[1] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany
[2] Univ Luxembourg, Dept Life Sci & Med DLSM, Belvaux, Luxembourg
[3] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Campus Belval,7,Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg
[4] Univ Luxembourg, Dept Life Sci & Med, Esch Sur Alzette, Luxembourg
[5] Saarland Univ, Med Ctr, Dept Internal Med 2, Homburg Saar, Germany
[6] Saarland Univ, Med Ctr, Dept Psychiat, Homburg Saar, Germany
关键词
parkinson's disease; epidemiology; cohort study; PREVALENCE; RISK; PESTICIDES; PENETRANCE; MORTALITY; RELEVANCE; SMOKING;
D O I
10.1177/1877718X241306132
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Epidemiologic evidence from different countries shows both increasing and decreasing incidence rates of Parkinson's disease over time without clear trends. Objective :We aimed to investigate age-specific incidence rates of Parkinson's disease and possible explanations for the observed trends in Germany over a 10-year period. Methods: Two different random samples of subjects aged >= 50 years included in 2004-2009 and 2014-2019, each consisting of 250,000 individuals, were drawn from Germany's largest health care insurance company followed up for new Parkinson's disease cases. We compared the age-specific incidence rates of Parkinson's disease for both cohorts and performed Cox regression models to calculate the hazard ratios (HR) of PD in the second period compared with the first period, adjusted for age, sex, and risk factors for Parkinson's disease. Results: For most age groups in men and in women, we found lower age-specific Parkinson's disease incidence rates in the second period. Cox regression analysis showed an overall 18% risk reduction in Parkinson's disease incidence (HR = 0.82, 95% confidence interval [0.76-0.89]). Mean age at diagnosis increased in men (+1.9 years) and women (+0.8 years). After adjustment for risk factors, the HR was 0.78 [0.72-0.85]. Sensitivity analysis considering the competing event of death showed an HR of 0.79 [0.73-0.86]), demonstrating the independence of time trends from changes in death rates. Conclusions: Our data show that the risk of Parkinson's disease has decreased over time and that this decrease is independent of factors such as changes in death rates, age structure, sex, and specific risk factors.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Incidence and prevalence of Parkinson's disease and utilization of antiparkinson treatments: A population-based cohort study
    Chen, Xihang
    Delmestri, Antonella
    Barclay, Nicola L.
    Pineda-Moncusi, Marta
    Sabate, Marti Catala
    Prieto-Alhambra, Daniel
    Jodicke, Annika M.
    Newby, Danielle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 465 - 465
  • [42] Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
    Eerik Hentilä
    Miia Tiihonen
    Heidi Taipale
    Sirpa Hartikainen
    Anna-Maija Tolppanen
    BMC Geriatrics, 21
  • [43] Association Between Exposure to Particulate Matter and the Incidence of Parkinson's Disease: A Nationwide Cohort Study in Taiwan
    Chen, Ting-Bin
    Liang, Chih-Sung
    Chang, Ching-Mao
    Yang, Cheng-Chia
    Yu, Hwa-Lung
    Wu, Yuh-Shen
    Huang, Winn-Jung
    Tsai, I-Ju
    Yan, Yuan-Horng
    Wei, Cheng-Yu
    Yang, Chun-Pai
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (03) : 313 - 321
  • [44] Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study
    Hentila, Eerik
    Tiihonen, Miia
    Taipale, Heidi
    Hartikainen, Sirpa
    Tolppanen, Anna-Maija
    BMC GERIATRICS, 2021, 21 (01)
  • [45] Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study
    Schrijvers, E. M. C.
    Verhaaren, B. F. J.
    Koudstaal, P. J.
    Hofman, A.
    Ikram, M. A.
    Breteler, M. M. B.
    NEUROLOGY, 2012, 78 (19) : 1456 - 1463
  • [46] Is Parkinson's disease-related mortality declining?
    Haberfeld, E.
    Louis, E. D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (09) : 964 - 965
  • [47] Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany
    Winter, Y.
    Balzer-Geldsetzer, M.
    Spottke, A.
    Reese, J. P.
    Baum, E.
    Klotsche, J.
    Rieke, J.
    Simonow, A.
    Eggert, K.
    Oertel, W. H.
    Dodel, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (09) : 1156 - 1163
  • [48] Pharmacotherapy of Parkinson’s disease in Germany
    J. C. Möller
    Y. Körner
    R. C. Dodel
    C. Meindorfner
    K. Stiasny-Kolster
    A. Spottke
    H. P. Krüger
    W. H. Oertel
    Journal of Neurology, 2005, 252 : 926 - 935
  • [49] Pharmacotherapy of Parkinson's disease in Germany
    Möller, JC
    Körner, Y
    Dodel, R
    Meindorfner, C
    Stiasny-Kolster, K
    Spottke, A
    Krüger, HP
    Oertel, W
    JOURNAL OF NEUROLOGY, 2005, 252 (08) : 926 - 935
  • [50] Declining trends in the rates of assisted injecting: a prospective cohort study
    Jeanette Somlak Pedersen
    Huiru Dong
    Will Small
    Evan Wood
    Paul Nguyen
    Thomas Kerr
    Kanna Hayashi
    Harm Reduction Journal, 13